logo
Select company
Select metric
Ticker Information

Ticker

POAI

Company Name

PREDICTIVE ONCOLOGY INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

PREDICTIVE ONCOLOGY INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

POAI - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 00%$ 1.07M
3/31/2025$ 6.48K0.48%$ 1.35M
12/31/2024$ 9.51K0.59%$ 1.62M
9/30/2024$ 2.21K0.16%$ 1.38M
6/30/2024$ 6.13K0.35%$ 1.75M
3/31/2024$ 255.01K13.01%$ 1.96M
12/31/2023$ 276.35K15.52%$ 1.78M
9/30/2023$ 341.6K18.89%$ 1.81M
6/30/2023$ 466.02K30.08%$ 1.55M
3/31/2023$ 398.84K27.88%$ 1.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PREDICTIVE ONCOLOGY INC's latest trailing twelve months (TTM) CapEx % stands at 9.13%.
  • Over the past 5 years, PREDICTIVE ONCOLOGY INC's average CapEx % has been 24.94%.
  • The median CapEx % for PREDICTIVE ONCOLOGY INC during this period was 27.88%
  • PREDICTIVE ONCOLOGY INC reached its highest CapEx % over the past 5 years at 64.08%.
  • The lowest CapEx % recorded by PREDICTIVE ONCOLOGY INC in the same timeframe 0.16%

PREDICTIVE ONCOLOGY INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
PAVM : PAVMED INC 2.35%CODX : CO-DIAGNOSTICS INC 73.77%APRE : APREA THERAPEUTICS INC -LUCY : INNOVATIVE EYEWEAR INC 3.39%LYRA : LYRA THERAPEUTICS INC -STSS : SHARPS TECHNOLOGY INC 933.54%VYNE : VYNE THERAPEUTICS INC 24.58%SXTP : 60 DEGREES PHARMACEUTICALS INC 11.13%BRTX : BIORESTORATIVE THERAPIES INC 17.73%SPRB : SPRUCE BIOSCIENCES INC -

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for PREDICTIVE ONCOLOGY INC is calculated as follows: CapEx [ $ 119.21K ] / Revenues [ $ 1.31M ]
(=) CapEx % [ 9.13% ]

POAI - Capital Expenditures Margin, Last 5 years

0.16%

Minimum

Sep 30, 2024

64.08%

Maximum

Dec 31, 2021

24.94%

Average

27.88%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%